KGZ-12740-86999
3 vaccinations
9 coded responses
27 check-ins
9 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 199 / DE
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Dose 1 — Moderna
-
2021-03-02
Registered in v-safe
-
2021-03-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-03
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-07
-
2021-03-10
Health check-in — day 7, dose 1Feeling: Poor · Chills · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Survey response — day 14, dose 1MedDRA: Headache — Feeling: Fair · Be unable to workFree text: Severe headache possible allergy symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Dose 2 — Moderna
-
2021-03-29
Health check-in — day 0, dose 2Feeling: Fair · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Injection site rash — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesFree text: Rash at and around injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling, Itching · Chills, Headache, Joint pains, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-07
Health check-in — day 7, dose 2Feeling: Poor · Headache, Abdominal pain · Be unable to workAdult check-in
- 2021-04-12
- 2021-04-19
-
2021-04-29
Survey response — day 28, dose 2MedDRA: Influenza like illness — Feeling: Fair · Be unable to workFree text: Feel like I have the fluMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-10
-
2021-06-28
Survey response — 3 months, dose 2MedDRA: Abortion spontaneous, Fatigue, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Runny nose. Tired. Miscarriage.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-27
Survey response — 6 months, dose 2MedDRA: Fatigue, Gastrointestinal disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fatigue, gastrointestinal issuesMedDRA releases: 2024-11 · check-in free text available
-
2021-09-27
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-09-29
-
2021-10-24
Dose 3 — ModernaCo-administered: Flu
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-10-31
Health check-in — day 7, dose 3Feeling: Fair · Fever · Headache, Joint pains · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-07
-
2021-11-14
Survey response — day 21, dose 3MedDRA: Headache, Paranasal sinus discomfort — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Headache sinus pressureMedDRA releases: 2024-11 · check-in free text available
- 2021-11-21
-
2021-11-28
Survey response — day 35, dose 3MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache fatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-12-05
- 2022-01-23
-
2022-04-26
Survey response — 6 months, dose 3MedDRA: Fatigue, Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue and cold like symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Survey response — 12 months, dose 3MedDRA: Multiple sclerosis, Office visit, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Symptoms: Multiple Sclerosis Flair/Relapse · Healthcare visit (other): Doctor appointments and infusionsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-10-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Moderna | |
| 2 | 2021-03-29 | Moderna | |
| 3 | 2021-10-24 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-27 | Successful 2022-10-27 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-10-26 | Successful 2022-10-27 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 5 — day 14, dose 1
Symptoms: Severe headache possible allergy symptoms
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Rash at and around injection site
Release 8 — day 28, dose 2
Symptoms: Feel like I have the flu
Release 9 — 3 months, dose 2
Symptoms: Runny nose. Tired. Miscarriage.
Release 9 — 6 months, dose 2
Symptoms: Fatigue, gastrointestinal issues
Release 10 — day 21, dose 3
Symptoms: Headache sinus pressure
Release 10 — day 35, dose 3
Symptoms: Headache fatigue
Release 11 — 6 months, dose 3
Symptoms: Fatigue and cold like symptoms
Release 12 — 12 months, dose 3
Symptoms: Multiple Sclerosis Flair/Relapse
Healthcare visit (other): Doctor appointments and infusions
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Influenza like illness | ✓ | ✓ | ✓ |
| SD | Multiple sclerosis | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Injection site rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release